A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810)
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacodynamics/pharmacokinetics of 5 mg, 10 mg,
20 mg and 40 mg of Rabeprazole sodium (E3810) when administered repeatedly once daily for 5
days to healthy adult male Japanese participants. This was a single-center, open-label,
randomized, four-treatment, four-way crossover study.